论文部分内容阅读
在不孕病人的处理上,用快速的免疫化学法测定排卵前LH 峰已为一种确定的方法,简捷的尿酶免测定已可行。作者对33例因不孕或月经过少而就诊的病人进行了研究,每例试用3个周期,仅11例可能评价。对18例监护34个自然周期未用任何治疗,15例的29个周期用克罗米芬(CC)刺激(100mg,周期5~9天),病人年龄21~39岁(29.8±4.5岁)。指导妇女收集晨尿行OvuQuick 自身试验,另外在每个研究日期取部分尿标本,通过半定量血凝封闭试验(HI-Gonavis)检测黄体生成素浓度,它可做为很好的参考方法,并通过OvuQuick 试验。从实验室得到HI-Gonavis 结果前要求病人报告其OvuQuick 结果,412份尿标本通过病人和实验室分析,周期中通过2种试验的测定与LH 峰相符合时定为排卵。在不同尿试验结果的
In the treatment of infertile patients, the rapid immunochemical determination of ovulation LH peak has been a sure way, simple urinary enzyme immunoassay has been feasible. The authors studied 33 patients who became inoperable due to infertility or menorrhagia. Each trial ran for 3 cycles, with only 11 evaluable. Fifteen of the 18 patients were monitored without any treatment for 34 natural cycles. Fifteen of 29 cycles were stimulated with clomiphene citrate (100 mg, cycles 5-9 days) and patients were 21-39 years (29.8 ± 4.5 years). Instruct women to collect OvuQuick’s own test for morning urine and take a portion of the urine samples on each study day and detect luteinizing hormone by HI-Gonavis, which is a good reference and Passed OvuQuick test. Patients were asked to report their OvuQuick results prior to obtaining HI-Gonavis results from the laboratory. 412 urine samples were analyzed by both patients and laboratories, and ovulation was determined when the two tests passed the cycle in agreement with the LH peak. Results of different urine tests